Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapy.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Controlled Release

• Publication date

  2015-12-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jconrel.2015.09.068PMID 26437261PMCID PMC4688183
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tuning Surface Charge and PEGylation of Biocompatible Polymers for Efficient Delivery of Nucleic Acid or Adenoviral Vector.

  2015cited by this paper
• Adenovirus expressing dual c-Met-specific shRNA exhibits potent antitumor effect through autophagic cell death accompanied by senescence-like phenotypes in glioblastoma cells

  2015cited by this paper
• Oncolytic Adenovirus Coated with Multidegradable Bioreducible Core-Cross-Linked Polyethylenimine for Cancer Gene Therapy.

  2015influential reference
• pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis.

  2015cited by this paper
• Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery.

  2014cited by this paper
• Enhanced therapeutic efficacy of an adenovirus-PEI-bile-acid complex in tumors with low coxsackie and adenovirus receptor expression.

  2014influential reference
• Safety Profiles and Antitumor Efficacy of Oncolytic Adenovirus Coated with Bioreducible Polymer in the Treatment of a CAR Negative Tumor Model

  2014cited by this paper
• Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma

  2013cited by this paper
• Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy.

  2013cited by this paper
• Therapeutic efficacy of a systemically delivered oncolytic adenovirus - biodegradable polymer complex.

  2013cited by this paper
• Targeting MET in cancer: rationale and progress

  2012cited by this paper
• Targeting MET in cancer: rationale and progress

  2012cited by this paper
• Gene-carried hepatoma targeting complex induced high gene transfection efficiency with low toxicity and significant antitumor activity

  2012cited by this paper
• Evolution of oncolytic adenovirus for cancer treatment.

  2012cited by this paper
• Cell targeting peptide conjugation to siRNA polyplexes for effective gene silencing in cardiomyocytes.

  2012cited by this paper
• Endosomal escape pathways for delivery of biologicals.

  2011cited by this paper
• Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin.

  2011cited by this paper
• Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA.

  2011cited by this paper
• A serum-resistant polyamidoamine-based polypeptide dendrimer for gene transfection.

  2011cited by this paper
• The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy.

  2010cited by this paper
• Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems.

  2009influential reference
• Cross‐talk between the VEGF‐A and HGF signalling pathways in endothelial cells

  2009cited by this paper
• Novel biodegradable poly(disulfide amine)s for gene delivery with high efficiency and low cytotoxicity.

  2008influential reference
• Gene therapy: the first approved gene-based medicines, molecular mechanisms and clinical indications.

  2008cited by this paper
• Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide.

  2008cited by this paper
• Overcoming the extracellular matrix barrier to improve intratumoral spread and therapeutic potential of oncolytic virotherapy.

  2008cited by this paper
• Cancer selective adenoviruses.

  2007cited by this paper
• E1A- and E1B-Double Mutant Replicating Adenovirus Elicits Enhanced Oncolytic and Antitumor Effects

  2007cited by this paper
• Screening and Identification of a Targeting Peptide to Hepatocarcinoma from a Phage Display Peptide Library

  2007cited by this paper
• Current status of polymeric gene delivery systems.

  2006cited by this paper
• Recent progress in the battle between oncolytic viruses and tumours

  2005cited by this paper
• Adenovirus-based cancer gene therapy.

  2005cited by this paper
• Current Status of Gendicine in China: Recombinant Human Ad-p53 Agent for Treatment of Cancers

  2005cited by this paper
• Nonviral gene delivery: techniques and implications for molecular medicine

  2003cited by this paper
• Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation

  2003cited by this paper
• Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine.

  2002cited by this paper
• Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages.

  2001cited by this paper
• Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

  1993cited by this paper

• Current advance of nanotechnology in diagnosis and treatment for malignant tumors

  2024cites this paper
• Recent advances in oncolytic virus therapy for hepatocellular carcinoma

  2023cites this paper
• Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements

  2021cites this paper
• Optimizing Active Tumor Targeting Biocompatible Polymers for Efficient Systemic Delivery of Adenovirus

  2021cites this paper
• Overcoming the barriers to optimization of adenovirus delivery using biomaterials: Current status and future perspective.

  2021cites this paper
• Tumor localization of oncolytic adenovirus assisted by pH-degradable microgels with JQ1-mediated boosting replication and PD-L1 suppression for enhanced cancer therapy.

  2020cites this paper
• A HCBP1 peptide conjugated ruthenium complex for targeted therapy of hepatoma.

  2020cites this paper
• Retargeting adenoviruses for therapeutic applications and vaccines

  2020cites this paper
• Recent advances in polymeric drug delivery systems

  2020cites this paper
• Advances in delivery vectors for gene therapy in liver cancer.

  2019cites this paper
• Recent Development of Bio-Reducible Polymers for Efficient Gene Delivery System

  2018cites this paper
• Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients

  2017cites this paper
• Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.

  2016cites this paper
• Oncolytic virotherapy for urological cancers

  2016cites this paper